COVID-19 vaccine start-up files for IPO
The biotech startup behind the COVID-fox19 vaccine jointly developed by AstraZeneca PLC and the University of Oxford filed Friday with U.S. regulators for a public share offering. Vaccitech PLC said in a securities filing it plans to use the technology underpinning the vaccine to develop treatments targeting prostate cancer, hepatitis B and human papillomavirus.
Several clinics pause J&J vaccines after 'adverse' reactions; CDC finds no safety issues
Federal health officials have been evaluating incidents in Georgia, Iowa, Colorado and North Carolina but have not "found any reason for concern."
Pfizer requests emergency use authorization to administer COVID-19 vaccine to kids ages 12-15
Pharmaceutical giant Pfizer announced on Friday that it submitted a request for emergency use authorization to begin administering its COVID-19 vaccine to adolescents between the ages of 12 and 15 in the U.S.
CDC: Expect schools to be fully reopened come September 2021
New York Post columnist Karol Markowicz reacts to kids expected back in the classroom full-time this Fall on 'FOX Business Tonight'
Biden: New goal is 200M vaccine shots in 100 days
FOX News medical contributor Dr. Nicole Saphier weighs in on president's new plan on 'FOX Business Tonight'
COVID-19 vaccine distribution is ‘great news’ for travel and tourism: Marriott International CEO
Marriott International CEO Tony Capuano tells ‘Your World’ wider distribution of vaccines will ‘really drive confidence’ about the safety of travel.
FDA advisory panel recommends authorization of Pfizer COVID-19 vaccine
Fox News correspondent David Spunt joins 'Special Report' with the latest from FDA headquarters in Silver Spring, Md.
Pharmaceutical executives update congressional lawmakers on COVID vaccine development
U.S. health officials remain optimistic a coronavirus vaccine could be ready by later this year or early 2021; Casey Stegall reports from Dallas.
Oxford University expects positive COVID vaccine news within days
Developers rush to have coronavirus vaccine ready by fall; insight from Fox News medical contributor Dr. Marc Siegel.
Infectious disease expert on efforts to flatten coronavirus curve, whether states can safely reopen
Dr. Tom Inglesby, director of the Center for Health Security at Johns Hopkins University, joins Chris Wallace on 'Fox News Sunday.'